Companies / Avalo Therapeutics, Inc. / Activity
Activity — Avalo Therapeutics, Inc.
1 move.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Doyle Mittie Executive | Sell | Common Stock | $411.6K | -25K -87.56% | 3,622 <0.01% of shares | medium |